Loading...
OTCMNSHSF
Market cap287kUSD
Dec 20, Last price  
0.03USD
Name

NanoSphere Health Sciences Inc

Chart & Performance

D1W1MN
OTCM:NSHSF chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
16.26%
Rev. gr., 5y
116.57%
Revenues
0k
0000000000041,20047,93737,881218,0340000
Net income
-228k
L-19.03%
0000162,2770000000-9,909,628-4,514,705-3,468,744-591,220-356,270-281,752-228,127
CFO
-54k
L-20.63%
0000404,8250000000-1,261,117-3,238,880-1,079,519-47,257-64,680-67,660-53,699

Profile

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
URL
https://www.nanospherehealth.com/
IPO date
Aug 11, 2005
Employees
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
Cost of revenue
220
284
386
Unusual Expense (Income)
NOPBT
(220)
(284)
(386)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(220)
(284)
(386)
Net income
(228)
-19.03%
(282)
-20.92%
(356)
-39.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
191
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(9)
(55)
(131)
Cash flow
Cash from operating activities
(54)
(68)
(65)
CAPEX
Cash from investing activities
Cash from financing activities
182
FCF
33
(47)
(691)
Balance
Cash
9
55
131
Long term investments
Excess cash
9
55
131
Stockholders' equity
(1,556)
(1,312)
(1,075)
Invested Capital
ROIC
ROCE
14.14%
21.64%
35.89%
EV
Common stock shares outstanding
10,275
10,275
6,815
Price
Market cap
EV
EBITDA
(220)
(284)
(386)
EV/EBITDA
Interest
13
Interest/NOPBT